PUBLIC LAW 106-545—DEC. 19, 2000 114 STAT. 2723 Sciences) from an academic institution, a State government agency, an international regulatory body, or any corporation developing or marketing new or revised or alternative test methodologies, including contract laboratories. (B) NONVOTING EX OFFICIO MEMBERS. — The membership of the SAC shall, in addition to voting members under subparagraph (A), include as nonvoting ex officio members the agency heads specified in subsection (c) (or their designees), (e) DUTIES. —The ICCVAM shall, consistent with the purposes described in subsection (b), carry out the following functions: (1) Review and evaluate new or revised or alternative test methods, including batteries of tests and test screens, that may be acceptable for specific regulatory uses, including the coordination of technical reviews of proposed new or revised or alternative test methods of interagency interest. (2) Facilitate appropriate interagency and international harmonization of acute or chronic toxicological test protocols that encourage the reduction, refinement, or replacement of animal test methods. (3) Facilitate and provide guidance on the development of validation criteria, validation studies and processes for new or revised or alternative test methods and help facilitate the acceptance of such scientifically valid test methods and awareness of accepted test methods by Federal agencies and other stakeholders. (4) Submit ICCVAM test recommendations for the test method reviewed by the ICCVAM, through expeditious transmittal by the Secretary of Health and Human Services (or the designee of the Secretary), to each appropriate Federal agency, along with the identification of specific agency guidelines, recommendations, or regulations for a test method, including batteries of tests and test screens, for chemicals or class of chemicals within a regulatory framework that may be appropriate for scientific improvement, while seeking to reduce, refine, or replace animal test methods. (5) Consider for review and evaluation, petitions received from the public that— (A) identify a specific regulation, recommendation, or guideline regarding a regulatory mandate; and (B) recommend new or revised or alternative test methods and provide valid scientific evidence of the potential of the test method. (6) Make available to the public final ICCVAM test recommendations to appropriate Federal agencies and the responses from the agencies regarding such recommendations. (7) Prepare reports to be made available to the public Reports. on its progress under this Act. The first report shall be com- Deadline, pleted not later than 12 months after the date of the enactment of this Act, and subsequent reports shall be completed biennially thereafter. SEC. 4. FEDERAL AGENCY ACTION. 42 USC 285^4. (a) IDENTIFICATION OF TESTS. — With respect to each Federal Deadline, agency carrying out a program that requires or recommends acute or chronic toxicological testing, such agency shall, not later than
�
